CIVC - Overview: Cortisol, Inferior Vena Cava, Serum
Testing cortisol levels in the inferior vena cava Second-order testing wen cortisol measurement by immunoassay gives results that are not consistent with clinical symptoms, or if patients are known to, or suspected of, taking exogenous...
PGN - Overview: Pregabalin, Serum
Monitoring serum pregabalin (Lyrica) concentrations, assessing compliance, and adjusting dosage in patients
pH, Fecal
CSTCE - Overview: Cystatin C with Estimated Glomerular Filtration Rate (eGFR), Serum
Assessing kidney function in patients suspected of having kidney disease Monitoring treatment response in patients with kidney disease An index of glomerular filtration rate (GFR), especially in patients where serum creatinine may be...
Monitoring acute (ie, short-term) drug use in addiction treatment or pain management settings as part of a rotational drug testing strategy Presumptive screening for amphetamine, methamphetamine, opioids/opiates (targeting morphine,...
CSFP - Overview: Carrier Screen, Focused Panel, Varies
Expanded carrier screening for reproductive risk assessment purposes This test is not useful for clinical diagnosis of an affected individual.
2C19R - Overview: Cytochrome P450 2C19 Genotype, Varies
Identifying patients who may be at risk for altered metabolism of drugs that are modified by cytochrome P450 2C19 Predicting anticoagulation response to clopidogrel
F81B - Overview: Hemophilia A F8 Gene, Intron 1 Inversion Known Mutation, Whole Blood
First-tier molecular testing for male patients affected with severe hemophilia A, when a familial intron 1 inversion has been previously identified Determining hemophilia A carrier status for at-risk female patients, ie, individuals with...
Detection of acute hepatitis C virus (HCV) infection before the appearance of HCV antibodies in serum (ie, <2 months from exposure) in women who are pregnant Detection and confirmation of chronic HCV infection in women who are...
TFH - Overview: FH Mutation Analysis, Next-Generation Sequencing, Tumor
Identifying specific mutations within the FH gene to assist in tumor diagnosis/classification, including renal cell carcinoma, uterine/cutaneous leiomyoma, and pheochromocytoma/paraganglioma
Perspectives Archives - Page 5 of 9 - Insights
Skip to Content MayoACCESS MayoLINK...
Research Archives - Page 5 of 33 - Insights
Skip to Content MayoACCESS MayoLINK...
People Archives - Page 5 of 35 - Insights
Skip to Content MayoACCESS MayoLINK...
Industry Archives - Page 5 of 6 - Insights
Skip to Content MayoACCESS MayoLINK...
Testing Archives - Page 5 of 26 - Insights
Skip to Content MayoACCESS MayoLINK...